BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29907593)

  • 21. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
    Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
    Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
    Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
    J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
    Oh CJ; Ha CM; Choi YK; Park S; Choe MS; Jeoung NH; Huh YH; Kim HJ; Kweon HS; Lee JM; Lee SJ; Jeon JH; Harris RA; Park KG; Lee IK
    Kidney Int; 2017 Apr; 91(4):880-895. PubMed ID: 28040265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
    Ho N; Coomber BL
    Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
    Tambe Y; Terado T; Kim CJ; Mukaisho KI; Yoshida S; Sugihara H; Tanaka H; Chida J; Kido H; Yamaji K; Yamamoto T; Nakano H; Omura S; Inoue H
    Mol Carcinog; 2019 Oct; 58(10):1726-1737. PubMed ID: 31106493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.
    Lu H; Lu Y; Xie Y; Qiu S; Li X; Fan Z
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
    Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
    Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer.
    Woolbright BL; Rajendran G; Abbott E; Martin A; Didde R; Dennis K; Harris RA; Taylor JA
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
    Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.
    Schafer C; Young ZT; Makarewich CA; Elnwasany A; Kinter C; Kinter M; Szweda LI
    J Biol Chem; 2018 May; 293(18):6915-6924. PubMed ID: 29540486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate.
    Seth P; Grant A; Tang J; Vinogradov E; Wang X; Lenkinski R; Sukhatme VP
    Neoplasia; 2011 Jan; 13(1):60-71. PubMed ID: 21245941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
    Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH
    Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
    Ryu H; Jin H; Ho JN; Bae J; Lee E; Lee SE; Lee S
    Biol Pharm Bull; 2019; 42(1):66-72. PubMed ID: 30606990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.
    Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
    Br J Cancer; 2010 Jun; 102(12):1746-52. PubMed ID: 20485289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
    Kim TS; Lee M; Park M; Kim SY; Shim MS; Lee CY; Choi DH; Cho Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.
    Li G; Li M; Hu J; Lei R; Xiong H; Ji H; Yin H; Wei Q; Hu G
    Oncogene; 2017 Feb; 36(7):989-998. PubMed ID: 27641336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.